With some therapeutics proving ineffective in as many as 75% of the patients they are expected to help, the need for personalized and precision medicine is clear. Because the use of selection biomarkers can triple drug development success rates, we have expanded our portfolio to test more than routine safety and efficacy parameters.
As your global partner for integrated clinical trial laboratory and diagnostic solutions, our goal at Cerba Research is to generate early scientific insights that optimize your protocol. Our large portfolio of next-generation assays are designed for targeted approaches or broad immune profiling with multifactorial biomarkers. Benefit from our customized service to obtain innovative, flexible, and tailored solutions grounded in expert science.
Optimize biomarker strategies for precision medicine
Beyond monitoring the efficacy of a drug by PK & PD, biomarkers are increasing in importance and evolving quickly to:
- Guide dose selection
- Characterize mode of action
- Stratify patients
- Predict drug response
- Aid in prognosis
- Monitor disease
Streamline your development — and ensure quality
Our quality-driven approach includes analytically validated assays and GLP- and/or CLIA-certified labs. We tailor the best possible solution that meets your requirements to:
- Transfer assays developed in-house
- Assess method feasibility
- Develop and validate customized assays
- Obtain detailed sample analyses